Skip to main content
. 2016 Jan 15;6(2):331–340.

Table 2.

Differentially urinary proteins expressed between bladder cancer and healthy control

Master number Accession No. Gene Name Protein molecular weight Protein PI Pep. Counta Total ion score Fold changesb Overall trendc
1 Q14624 ITIH4 103521.1 6.51 5 251 -4.96±2.32 down
2 P12830 CDH1 97852 4.58 4 225 7.15±1.29 up
3 P07911 UMOD 72451.4 5.05 9 308 8.85±2.47 up
4 P04746 AMY2A 58354.3 6.6 8 290 5.39±2.31 up
5 P04746 AMY2A 58354.3 6.6 8 307 4.81±2.32 up
6 P01042 KNG1 72995.6 6.34 7 269 -3.74 ±1.39 down
7 P02768 ALB 71317.2 5.92 9 259 -8.31±1.71 down
8 P30740 SERPINB1 42828.7 5.9 5 273 -5.96±2.78 down
9 P01842 IGLC1 11400.6 6.92 3 132 -4.77±1.51 down
10 P02647 APOA1 30758.9 5.56 5 238 4.56±1.79 up
11 P02763 ORM1 23724.8 4.93 3 282 6.81±2.56 up
12 P02763 ORM1 23724.8 4.93 3 298 7.78±3.12 up
13 P01842 IGLC1 11400.6 6.92 3 142 -8.04±3.89 down
14 P02753 RBP4 23337.4 5.76 2 267 5.61±2.81 up
15 P28325 CST5 16080.5 6.71 2 157 2.78±1.23 up
a

Calculated by amino acid count.

b

Calculated based on the spot intensity analysis, represented as mean ± SD.

c

up: up-regulated in the bladder cancer group. down: down-regulated in the bladder cancer group.